Michaela Schwarz Selected Research

Michaela Schwarz Research Topics

14	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 04/2014 - 01/2002
7	Philadelphia Chromosome 01/2015 - 10/2002
3	Leukemia 01/2022 - 10/2002
2	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 01/2022 - 01/2015
2	Neoplasms (Cancer) 01/2014 - 01/2013
2	Blast Crisis (Blast Phase) 10/2010 - 04/2010
1	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 01/2021
1	Myocardial Infarction 01/2021
1	Dyskeratosis Congenita (X-Linked Dyskeratosis Congenita) 01/2021
1	Primary Myelofibrosis (Myelosclerosis) 01/2020
1	Body Weight (Weight, Body) 11/2019
1	Sudden Infant Death (SID) 10/2017
1	Postoperative Nausea and Vomiting (PONV) 10/2017
1	Chronic Kidney Failure (Chronic Renal Failure) 08/2015
1	Critical Illness (Critically Ill) 08/2015
1	Renal Insufficiency (Renal Failure) 08/2015
1	Acute Kidney Injury (Acute Renal Failure) 08/2015
1	Neurodegenerative Diseases (Neurodegenerative Disease) 09/2014
1	Disease Progression 04/2014
1	Coronary Artery Disease (Coronary Atherosclerosis) 06/2012
1	Hyperthyroidism 11/2010
1	Hypothyroidism 11/2010
1	Autoimmune Thyroiditis (Lymphomatous Thyroiditis) 11/2010
1	Chromosome Aberrations (Chromosome Abnormalities) 04/2010
1	Parkinson Disease (Parkinson's Disease) 12/2008
1	Papillomavirus Infections 04/2003
1	Squamous Cell Carcinoma (Epidermoid Carcinoma) 04/2003
1	Carcinoma (Carcinomatosis) 04/2003
1	Acute Generalized Exanthematous Pustulosis 10/2002
1	Exanthema (Rash) 10/2002
1	Muscle Cramp (Cramp) 10/2002
1	Edema (Dropsy) 10/2002

10	Imatinib Mesylate (Gleevec)FDA Link 04/2014 - 01/2002
5	nilotinib FDA Link 01/2015 - 04/2010
5	Tyrosine Kinase InhibitorsIBA 06/2012 - 08/2003
3	AcidsIBA 10/2017 - 01/2002
3	Phosphotransferases (Kinase)IBA 01/2014 - 10/2002
2	Glycoproteins (Glycoprotein)IBA 08/2003 - 01/2002
2	Pharmaceutical PreparationsIBA 04/2003 - 10/2002
1	AndrogensIBA 01/2021
1	Janus Kinase InhibitorsIBA 01/2020
1	Triglycerides (Triacylglycerol)IBA 11/2019
1	Glucose (Dextrose)FDA LinkGeneric 11/2019
1	CholesterolIBA 11/2019
1	Phosphates (Orthophosphate)IBA 10/2017
1	CatecholaminesIBA 10/2017
1	ElectrolytesIBA 10/2017
1	Starch (Cornstarch)IBA 08/2015
1	Human Serum Albumin FDA LinkGeneric 08/2015
1	KynurenineIBA 09/2014
1	Quinolinic AcidIBA 09/2014
1	Biological ProductsIBA 09/2014
1	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 01/2014
1	Ketoglutaric Acids (Ketoglutaric Acid)IBA 01/2013
1	5-hydroxymethylfurfural (hydroxymethylfurfural)IBA 01/2013
1	Dasatinib (BMS 354825)FDA Link 11/2010
1	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 10/2003
1	Messenger RNA (mRNA)IBA 08/2003
1	Interferon-alpha (Interferon Alfa)IBA 08/2003
1	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 01/2002
1	bcr-abl Fusion ProteinsIBA 01/2002

9	Therapeutics 01/2022 - 01/2002
2	Drug Therapy (Chemotherapy) 01/2022 - 04/2003
2	Hematopoietic Stem Cell Mobilization 03/2011 - 10/2003
1	Hematopoietic Stem Cell Transplantation 01/2022
1	Consolidation Chemotherapy 01/2022
1	Length of Stay 08/2015
1	Transplantation 08/2011
1	Deep Brain Stimulation 12/2008